1 / 14

How cost influences access to medical abortion in the public and private sector

How cost influences access to medical abortion in the public and private sector. Sharad D. Iyengar Action Research & Training for Health (ARTH), Udaipur, Rajasthan, India Expanding Access to Medical Abortion: Building on two decades of Experience Lisbon, Portugal, 2-4 March 2010.

Download Presentation

How cost influences access to medical abortion in the public and private sector

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. How cost influences access to medical abortion in the public and private sector Sharad D. Iyengar Action Research & Training for Health (ARTH), Udaipur, Rajasthan, India Expanding Access to Medical Abortion: Building on two decades of Experience Lisbon, Portugal, 2-4 March 2010

  2. Access to medical abortion in the new millenium… • Mifepristone is registered in 44 countries, misoprostol in most, though not for abortion • In several countries, access to abortion services is legally restricted, while in some others with a relatively liberal law, weak implementation of the law leaves women with poor access Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  3. The cost of older, obsolete techniques • Dilatation and curettage (“D&C”) • Hypertonic (concentrated) saline • Ethacridine lactate dye • Intra/ extra- amniotic prostaglandins • Require more dilatation >> more pain control (general anesthesia) >> hospital admission >> longer travel, need for accompanying persons (lower confidentiality) • Less safe – more complications, including hemorrhage, perforation and infection • Health systems have responded to lower safety by over-medicalizing services Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  4. Modern abortion techniques • Manual or electric vacuum aspiration • Medical abortion • Dilatation and evacuation • Less pain and greater safety >> no anesthesia, less pain control, no admission, no need for an accompanying person • However, modern techniques require the state to invest as much or even more, for providing abortion services Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  5. Who pays…..? • Greater state investment in abortion services • Drug regulation and management of services • Developing human resources for delivering services • Equipment, supplies and logistics • Information and communication would be expected to reduce costs for the user • Instead, most governments have under-resourced SRH services, including those for safe abortion • Women compensate for poor access by paying more – directly and indirectly Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  6. What women pay • Direct costs for getting an abortion and/or managing complications • Formal or informal fees to providers and support staff • Hire and use of facilities • Drugs, supplies and antiseptics • Indirect costs for getting an abortion and following up • Travel to and from a provider or facility • Wage loss and arranging for domestic support • Travel and wage loss for companion Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  7. What the system must pay for A drug and services regulatory framework, which includes ground level monitoring of service - delivery Training institutions – better pedagogy, skills and opportunities for learning Delivery of information, support and drugs to the user Channels of information and communication – communicators, counselors and media (including internet) A referral system for dealing with failures and complications Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  8. Social / commercial marketing: of drugs or services? Of course, women self-medicate – for abortion, infertility, infections (STIs, TB, etc) just like men do High transaction costs of setting up commercial or social marketing operations In poorly regulated regions, large scale competitive delivery of drugs into the hands of (untrained or poorly trained/ informed) providers Women get the pills, with little information or back-up (India: 10.5 mi mife pills sold in 2009, but only about 800,000 reported abortion procedures) Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  9. Informal providers segment their market… Bihar and Jharkhand, India: • Lower paying customers – offered cheaper “ayurvedic” (herbal) pills • Higher paying customers – offered mife =/- misoprostol “First we give Gynomic Forte; if it does not work, we give Aromic Forte. If that does not work, we give misoprotol, then mifepristone, and finally we suggest, go to madam [nearby gynecologist]” (Ganatra B et al. RHM, 2005) • The actual use of abortion pills follows the logic of minimizing cost to the greatest extent possible Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  10. Women too, “segment the market” of providers Predominantly surgical abortion providers: • Highly qualified and safe • Intermediate • Unqualified and unsafe (Ramchandar L, Pelto PJ. RHM, 2004) • Based on collective experience, women assessed the cost of the service, the likelihood of complications and the cost of dealing with them, before opting for a service • Some delayed seeking a service till enough money was collected, to pay for a better provider • We may expect medical abortion services too, will be held to similar standards Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  11. The surgically inclined public sector Abortion services continue to be rooted in the “facility based surgical (D&C) procedure” paradigm Few countries provide medical abortion drugs through the public sector Even in the presence of rent-seeking, the cost to women is likely to become substantially lower, if abortion pills were provided or subsidized by the state The state is likely to thereby save on costs of surgical services, but the argument has to be well made Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  12. How best can provision of medical abortion reduce costs? By promoting and delivering medical abortion as a (high-quality) service rather than as a pharmaceutical product By freeing up controls and levies on the pills (as has been attempted for anti-retrovirals) By providing or financing the pills through the public sector, at least for the most vulnerable sections of the population Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  13. Changing technology: jumping two steps Telephone services Abortion services Health systems and providers continue to resist moving from D&C to VA or D&E Medical abortion allows countries to rapidly expand access without having to first provide surgical services Existing surgical services (with some required expansion) could be used as a referral back-up for incomplete procedures and failures • Right up to the nineties, telephone services were poorly accessible in several developing countries, in part because of the high cost of fixed telephone lines • The advent of mobile phones technology allowed countries to rapidly expand access without having to first provide fixed phone services Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

  14. The pill will…. Expanding Access to Medical Abortion; Lisbon, Portugal, 2-4 March 2010

More Related